Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Goodwill & Intangibles: 2023-2024

Historic Goodwill & Intangibles for Zevra Therapeutics (ZVRA) over the last 2 years, with Dec 2024 value amounting to $73.7 million.

  • Zevra Therapeutics' Goodwill & Intangibles fell 84.81% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year decrease of 84.81%. This contributed to the annual value of $73.7 million for FY2024, which is 0.32% down from last year.
  • Per Zevra Therapeutics' latest filing, its Goodwill & Intangibles stood at $73.7 million for FY2024, which was down 0.32% from $73.9 million recorded in FY2023.
  • Zevra Therapeutics' 5-year Goodwill & Intangibles high stood at $73.9 million for FY2023, and its period low was $73.7 million during FY2024.
  • In the last 2 years, Zevra Therapeutics' Goodwill & Intangibles had a median value of $73.8 million in 2023 and averaged $73.8 million.
  • Data for Zevra Therapeutics' Goodwill & Intangibles shows a maximum YoY fell of 0.32% (in 2024) over the last 5 years.
  • Over the past 2 years, Zevra Therapeutics' Goodwill & Intangibles (Yearly) stood at $73.9 million in 2023, then fell by 0.32% to $73.7 million in 2024.